MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Device and Methods for In Vivo Flow Cytometry: Non-invasive and Sensitive Detection of Circulating Cancer Cells using Photoacoustic Waves (08-16)

University of Arkansas for Medical Sciences
non invasive in vivo detection of cells circulating in blood or lymphatic vessels

Mechanism of action

a laser diode array and a photoacoustic detector

Full description

This device describes a laser diode array and a photoacoustic detector that operates as a non-invasive, in vivo, flow cytometer able to detect in a sensitive and real-time manner individual cells circulating within the human body.  Thus, for example, individual cancer cells in circulation could be detected at a level of 1 cancer cell in a background of 108.  Another potential utility of this device and method is the monitoring the course of therapy during cancer treatment using specific agents to identify and quantitate selected cellular markers.   Portable versions of this device are envisioned.

A prototype is available which non-invasively detects laser-induced photoacoustic waves which emanate from different cells, pathogens, microparticles, and nanoparticles.  The device located on the skin surface in proximity to circulating in blood vasculature or lymphatic vessels can detect and initiate therapeutic action on appropriately tagged circulating cells.

Ultrasound transducers attached to the skin of an organism detect the photoacoustic ultrasound waves emitted by target objects in response to their illumination by at least one pulse of laser energy delivered using a selected wavelength.  The wavelengths of the laser light pulse may be varied to optimize the absorption of the laser energy by the target object.  The target objects detected by the device may be unlabelled biological cells or cell products, contrast agents, or biological cells labeled with one or more contrast agents.

        Patent Pending 

       Available for exclusive licensing

08-16 Zharov

Development status

Preclinical

Patent information

U.S. Patent Application #12/334,217

Type of business relationship sought

 Seeking Partner to develop and commercialize this technology

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us